The explosion in the development of generative AI has been referred to as an “Oppenheimer” moment. Just last week, a group of more than 350 executives and scientists jointly stated that “[m]itigating the risk of extinction from AI should be a global priority alongside other societal-scale risks such as pandemics and nuclear war.” And more than 1,000 tech leaders have called for a moratorium on AI development until regulations governing its safe use are devised.
CMA’s heightened scrutiny of PE “roll-up” acquisitions: recent cases and lessons
By Paul Gilbert, John Kwan & Lanto Sheridan on
The UK Competition and Markets Authority (CMA) has identified “roll-up” acquisitions (the acquisition of several targets in the same sector) by financial investors, such as private equity firms, as an enforcement priority. In this post, we discuss the CMA’s enforcement focus, its recent decisional practice, and implications for merging parties. The main takeaways are:…